AHA 2015 First Report Header
EMPA-REG: Empagliflozin Cut Heart Failure Hospitalizations, CV Death in High-Risk Diabetes Patients

EMPA-REG: Empagliflozin Cut Heart Failure Hospitalizations, CV Death in High-Risk Diabetes Patients

Results showed a consistent benefit in both patients with and those without heart failure.

AHA 2015 Complete Coverage

AHA 2015 SPRINT: Lower Blood Pressure Target May Reduce Mortality, Cardiovascular Events

SPRINT: Lower Blood Pressure Target May Reduce Mortality, Cardiovascular Events

Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.

AHA 2015 MI-GENES: Genetic Risk Information May Motivate Patients to Lower LDL Cholesterol

MI-GENES: Genetic Risk Information May Motivate Patients to Lower LDL Cholesterol

Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.

AHA 2015 Fewer Adults Achieving Ideal Cardiovascular Health

Fewer Adults Achieving Ideal Cardiovascular Health

A decrease was noted in the number of people who score highly on 7 metrics of cardiovascular health defined by the AHA.

AHA 2015 Energy Drinks May Spike Blood Pressure, Norepinephrine Levels

Energy Drinks May Spike Blood Pressure, Norepinephrine Levels

Physicians may need to ask young adults about energy drink intake in emergency settings.

AHA 2015 Many Hispanic Patients Undertreated for High Cholesterol

Many Hispanic Patients Undertreated for High Cholesterol

Only one-third to one-half of eligible Hispanic patients studied are taking statins or other lipid-lowering therapies.

AHA 2015 Gender Disparities Exist in Cardiovascular Care

Gender Disparities Exist in Cardiovascular Care

Mortality rate is higher among women with heart disease after discharge from the hospital.

AHA 2015 Even Young Obese Children Have Evidence of Heart Disease

Even Young Obese Children Have Evidence of Heart Disease

Obese children as young as age 8 years have signs of heart disease and heart muscle abnormalities.

AHA 2015 Peer Group Intervention May Thwart Cardiovascular Disease

Peer Group Intervention May Thwart Cardiovascular Disease

Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.

AHA 2015 Many Women Unaware of Their Risk for CVD

Many Women Unaware of Their Risk for CVD

Many women in the United States do not feel personally connected to the risk of heart disease.

AHA 2015 3D Printing May Lead to Personalized Pills

3D Printing May Lead to Personalized Pills

Personalized medications based on a patient's medical and biological profiles may be possible with 3D printing.

Upcoming Meetings

Sign Up for Free e-Newsletters